LP-003 injection for allergic asthma
Treatments studied
Part of Immune system & allergy, Lungs & breathing clinical trials.
This trial tests an injection called LP-003 for people with allergic asthma that is not well controlled by current inhalers and other medications. It aims to see if the drug can improve asthma control and reduce flare-ups.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old
- You have had asthma for at least 1 year and it is allergic asthma
- You have had at least 1 asthma flare-up in the past year that needed steroids
- You use a medium to high dose inhaled steroid and at least one other asthma controller medication
- Your lung function test shows your breathing is between 40% and 80% of normal
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 trial tests whether FB825 can improve symptoms and safety in adults with moderate-to-severe allergic asthma. It is mainly for people whose asthma is not well controlled despite regular inhaler treatment.
This trial tests a new inhaled medication called LQ036 to see if it can help people whose asthma is not well controlled with their current inhalers. Participants must have had at least one severe asthma flare-up in the last year and show signs of airway inflammation.
This trial tests a new drug called IBI3002 for people with moderate to severe asthma that isn't well controlled with standard inhalers. It aims to see if the drug is safe and tolerable when given multiple times.
This trial tests an investigational medication called LP-003 to see if it can reduce allergic reactions to peanuts. It may help people who are allergic to peanuts be able to tolerate small amounts.
This trial tests if omalizumab, an allergy medication, can help people with COPD who have allergies to common indoor triggers like cat, dog, mouse, cockroach, or dust mite. It aims to reduce flare-ups and improve breathing.
This trial tests an experimental medication called SIM0718 to see if it can improve asthma control and reduce flare-ups. It may be an option for people whose asthma is not well-controlled with their current inhaler therapy.
Hear when a new Allergic Asthma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.